Deborah A Wing, MD
University of California, Irvine · University of California, Irvine Medical Center/Long Beach Memorial Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Deborah A Wing, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03129945 · Comparison of Nifedipine Versus Indomethacin for Acute Preterm LaborUniversity of California, Irvine · completed · Obstetric Labor, Premature · principal investigator
- Ph4NCT02049944 · Increased Cefazolin During Cesarean Delivery in Obese PopulationMemorialCare Health System · completed · Obesity, Obesity, Morbid, Pregnancy · principal investigator
- N/ANCT00514618 · Outpatient Cervical Ripening With Orally Administered Misoprostol in DiabeticsMemorialCare Health System · terminated · Diabetes, Gestational · principal investigator
- N/ANCT00506025 · Effectiveness of Cranberry Ingestion on Bacterial Adhesion: An Adjunct StudyUniversity of California, Irvine · completed · Asymptomatic Bacteriuria · principal investigator
- N/ANCT00503672 · Assessment of Activity in Pregnancy Using an ActigraphUniversity of California, Irvine · withdrawn · Motor Activity, Pregnancy · principal investigator
- Ph1NCT00093938 · Cranberry Juice for Preventing Bacteria in Urine During PregnancyNational Center for Complementary and Integrative Health (NCCIH) · completed · Urinary Tract Infection, Bacteriuria · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:52 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.Lancet Oncol · 2022142 citationsRCR 9.9
- 76 citationsRCR 2.6
- A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.Pediatr Blood Cancer · 201676 citationsRCR 2.7
- 58 citationsRCR 4.1
- A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.Int J Cancer · 201748 citationsRCR 1.7
- Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing.Clin Cancer Res · 201440 citationsRCR 1.2
- Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.J Clin Oncol · 202438 citationsRCR 4.6
- 18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.J Nucl Med · 201837 citationsRCR 1.7
- Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial.Clin Cancer Res · 201937 citationsRCR 1.7
- Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI.Br J Cancer · 201527 citationsRCR 1.1